Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Carcinoma, Hepatocellular 25Carcinoma, Non-Small-Cell Lung 14Squamous Cell Carcinoma of Head and Neck 11Melanoma 10Breast Neoplasms 10Urinary Bladder Neoplasms 9Colorectal Neoplasms 9Lung Neoplasms 6Cholangiocarcinoma 6Carcinoma, Renal Cell 6Biliary Tract Neoplasms 6Adenocarcinoma Of Esophagus 6Ovarian Neoplasms 5Liver Neoplasms 5Diabetes Mellitus, Insulin-Dependent, 12 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Pancreatic Neoplasms 4Mesothelioma, Malignant 4Head and Neck Neoplasms 4Neoplasm Metastasis 3Mesothelioma 3Kidney Neoplasms 3Fallopian Tube Neoplasms 3Endometrial Neoplasms 3Carcinoma, Transitional Cell 3Vulvar Neoplasms 2Vaginal Neoplasms 2

Interventions

Iodine-131 5dabrafenib 4Vemurafenib 4Magnetic Resonance Spectroscopy 4trametinib 3lenvatinib 3Transurethral Resection of Prostate 3Thyrotropin Alfa 3Thyroidectomy 3selpercatinib 2cobimetinib 2X-Rays 2Thyroid (USP) 2Surgical Procedures, Operative 2Sunitinib 2Specimen Handling 2Radiofrequency Ablation 2Interviews as Topic 2vandetanib 1tremelimumab 1spartalizumab 1pembrolizumab 1pazopanib 1durvalumab 1delta 24-sterol reductase 1copanlisib 1cabozantinib 1Whole Body Imaging 1Thyrotropin 1Thalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Thyroid Cancer, Papillary × tremelimumab × Clear all
NCT03753919 2026-03-11

DUTHY

Grupo Espanol de Tumores Neuroendocrinos

Phase 2 Terminated
79 enrolled 25 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡